Cannabis News and Research

Latest Cannabis News and Research

Animal studies reveal brain changes responsible for appetite effects of cannabis

New research on how cannabis use alters eating behavior could lead to treatments for appetite loss in chronic illness, according to experts at Washington State University.

17 Jul 2018

Study: White adolescent boys experiencing early puberty have high risk for substance use

White adolescent boys experiencing early puberty are at higher risk for substance use than later developing boys, a new Purdue University study finds.

17 Jul 2018

Pre-clinical pilot study shows promising results of 'concussion pill'

In 2016, funded by a $16 million grant from Scythian, the multidisciplinary Miller School team embarked on a five-year study to examine the effects of combining CBD (a cannabinoid derivative of hemp) with an NMDA antagonist (an anesthetic used in animals and humans) for the treatment of traumatic brain injury and concussion.

16 Jul 2018

Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer

A class of molecules formed when the body metabolizes omega-3 fatty acids could inhibit cancer's growth and spread, University of Illinois researchers report in a new study in mice.

16 Jul 2018

Research sheds light on composition of cannabis used to treat children with epilepsy

A pioneering study has found Australian parents who turned to medicinal cannabis to treat children with epilepsy overwhelmingly (75 percent) considered the extracts as "effective". Contrary to parental expectations, extracts generally contained low doses of cannabidiol - commonly considered to be a key therapeutic element and that has been successfully used in recent clinical trials to treat epilepsy.

5 Jul 2018

Illicit drug supply at record heights

According to a 2018 World Drug report released by the United Nations Office on Drugs and Crime (UNODC) this week (26th June 2018) the supply of illicit drugs such as cocaine, opium and heroin have reached record heights.

28 Jun 2018

FDA approves cannabis based drug for severe form of epilepsy

The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.

28 Jun 2018

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

Study finds increase in daily cannabis use among American adults

Cannabis use may be decreasing among teens, but a new study by researchers at Columbia University's Mailman School of Public Health showed that American adults have increasingly used cannabis daily since 2007. The findings are published online in the Journal of Studies on Alcohol and Drugs.

20 Jun 2018

Researchers find no link between cannabis use and suicidal behavior in psychiatric patients

McMaster University researchers have found there is no significant association between cannabis use and suicidal behavior in people with psychiatric disorders.

13 Jun 2018

Synthetic cannabis use may increase risk of heart attack and stroke

The warning follows their treatment of a 25 year old prison inmate who had no family history of heart disease or traditional cardiovascular risk factors, and who was left with a permanent disability.

8 Jun 2018

With the rise of legal weed, drug education moves from ‘don’t’ to ‘delay’

California legalized marijuana in 2016, and this past New Year’s Eve eager customers lined up in the darkness outside medical marijuana dispensaries across the state, ready to start shopping at the stroke of midnight.

7 Jun 2018

Opioid misuse may compromise effectiveness of treatments for alcohol use disorder

New research indicates that opioid misuse and the use of cannabis and other drugs may compromise the effectiveness of treatments for alcohol use disorder.

6 Jun 2018

Illinois looks at medical marijuana use for opioid dependence

Illinois officials are now considering the use of medical marijuana to combat the rising menace of opioid abuse and dependence. A Senate bill that allows people who qualify to fill opioid prescriptions to be able to apply for medical cannabis program of the state has been placed.

28 May 2018

Children and adolescents growing up in extreme societal conditions more likely to resort to violence

Children and adolescents who grow up with one or more of these environmental risk factors are likely to resort to violence, aggression and crime as adults, irrespective of an underlying mental illness.

24 May 2018

Early-onset cannabis use linked to further drug abuse problems

What a difference a year or two can make: If you started smoking marijuana at the start of your teens, your risk of having a drug abuse problem by age 28 is 68 per cent, but if you started smoking between 15 and 17 your risk drops to 44 per cent, according to a new study by Université de Montréal researchers.

21 May 2018

FutureNeuro and GreenLight Medicines team up to develop cannabis-based treatments for epilepsies

A new partnership between FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological diseases based at RCSI and GreenLight Medicines, an indigenous Irish biopharmaceutical company has been formed to develop new cannabis-based treatments for drug-resistant epilepsies, and in particular, childhood epilepsies.

17 May 2018

Experts discuss how medicinal cannabis can impact opioid crisis

A multidisciplinary panel of experts discussed how medicinal cannabis can impact the opioid crisis, though clinical research to quantify this is difficult given strict federal laws

9 May 2018

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

Researchers at University of California San Diego School of Medicine are preparing a first-of-its-kind, multidisciplinary investigation to determine if and how cannabidiol, a non-psychoactive compound found in the cannabis plant, provides therapeutic benefit to children with severe symptoms of autism spectrum disorder.

27 Apr 2018

New app could improve safety of cannabis use

Although cannabis, also known as marijuana, has been shown to impair memory, reaction time and attention, it is difficult to assess this impairment in a natural setting. Researchers have developed a prototype app called 'Am I Stoned' that could help cannabis users understand how the drug is affecting them through a series of phone-based tasks.

25 Apr 2018